FDA Investigator Matthew A Spataro

Matthew A Spataro has conducted inspections on 73 sites in 3 countries as of 16 Dec 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
73
Last Inspection Date:
16 Dec 2013
Investigator Role:
FDA Investigator
Redica ID:
100000331
Countries of Inspections:
United States of America, Germany, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Matthew A Spataro:
Alberto A Viciedo, Alice S Tsao, Allen Lou, Amatul H Marium, Amber D Brodas, Anissa M Vargas, Ann M Stewart, Ann Marie Montemurro, Anna M Alexander, Annemarie B Randow, Annemarie Bodnar, Antonina Aydanian, Arduino Frankovic, Arsen Karapetyan, Ayorinde O Babalola, Aziz A Mamur, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara M Frazier, Benton M Ketron, Bijoy Panicker, Bruce H Mccullough, Byungja E Marciante, Carla A Norris, Cary Greene, Charanjeet Jassal, Charisse K Green, Charles J Chacko, Charles Jewell, Cheryl A Grandinetti, Christina N Maurino, Clotia Cabbey Mensah, Concepcion Cruz, Jr, Cynthia Jim, CSO, Daniel J Grabicki, David H Smith, David R Delucia, Deborah B Nixon, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Diane L Raccasi, Dinesh Kumar, Donald G Gordon, Donna Mwilliams Hill, PhD, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Emmanuel Jramos Maldonado, Eric Rothschild, Erin D Mccaffery, Evan Tong, Felix Maldonado, Frank Verni, Frank Wackes, Freyja V Lynn, Gale E Ryan, Gam S Zamil, Gary T Greco, George Pyramides, Gianine E Tompkins, Gifford Whitehurst, Jr, Gloria E Parra, Gregson A Joseph, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, Iram R Hassan, PhD, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jagdish R Amin, James A Liubicich, James C Maclaughlin, James M Mason, Jane C Chen, Janet A Rajan, Jason Kwong, Jawaid Hamid, Jean M Kelahan, Jennifer L Bridgewater, Joan A Loreng, Jogy George, John A Podsadowski, John E Aghadia, Jose Acruz Gonzalez, Jose M Cayuela, Joseph Milcetic, Joy P Matthias, Joy Rkozlowski Klena, Julie D Bringger, Junho Pak, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Kassa Ayalew, MD, Keith M Reilly, Kelli F Dobilas, Kellie Leveille, Kenneth H Williams, Kerun Hardeo, Kevin A Gonzalez, Kristen D Evans, Kristina L Conroy, Kristy A Zielny, Kumar G Janoria, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Larry K Austin, Lata C Mathew, PhD, Lawrence W Farina, Leena Thomas, Li Li, Liatte Kreuger, PharmD, Lirissia Mccoy, Lisa Harlan, Lori Peters, LTJG Matthew R Palo, Manhar R Patel, Maotang Zhou, PhD, Marcus F Yambot, Margaret E Sarles, Margaret M Annes, Maria Joselopez Barragan, PhD, Marjorie A Shapiro, PhD, Marsha W Major, Marshalette O Edwards, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew B Casale, Mayar M Mussa, Melba Trivera Clavell, Melissa T Roy, Meyer J Slobotsky, Michael A Charles, Michael Levin, Michael R Dominick, Michael R Klapal, Michael Serrano, Mihaly S Ligmond, Milan S Blake, Milan S Mcgorty, Mindy M Chou, Mra Mcculloughj, Nancy A Saxenian Emmons, Nancy F Scheraga, Nancy L Rolli, Nancy T Waites, Neil J Bonzagni, PhD MPH, Niketa Patel, Nina Yang, Omotunde O Osunsanmi, Parul M Patel, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula A Trost, Perry T Nichols, Peter Abel, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Raymond M Lam, Regina T Brown, Richard W Thornton, Robert C Steyert, Robert G Ruff, Robert Jennings, Robin P Mathew, Rochelle K Kimmel, Rodney T Allnutt, Roger F Zabinski, Russell J Glapion, Samuel T Walker, Sandra A Hughes, Sandra D Thompson, Sarah A Meehan, Sarah B Tanksley, Satheesh Thomas, Sayyem H Akbar, Scott E Norris, Shari L Kahn, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stella Yuen, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Stephen R Souza, Steven B Hertz, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susan T Hadman, Syeda N Mahazabin, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara K Carmody, Tara R Gooen, Ted L Anderson, Tej Poonai, Thomas P Hansen, Tina S Roecklein, Tonia F Bernard, Tyanna N Hadley, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Vanessa M Williams, Vivin George, Wayne E Seifert, Willy A Orantes, Winston R Alejo, Xiaoping Guan, Xikui Chen (nmi), PhD, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhijin Chen, Zhongren Wu

Matthew A Spataro's Documents

Publish Date Document Type Title
May, 2003 FDA 483 Barr Laboratories Inc. - Form 483, 2003-05-09
January, 2001 FDA 483 Merck & Co., Inc. - Form 483, 2001-01-19
April, 2013 EIR ScieGen Pharmaceuticals INC - EIR, 2013-04-02
July, 2002 EIR ENDO USA, Inc. - EIR, 2002-07-01
November, 2002 FDA 483 Barr Laboratories Inc. - Form 483, 2002-11-12
September, 2003 FDA 483 Silarx Pharmaceutical, Inc. - Form 483, 2003-09-17
February, 2002 FDA 483 AMA Laboratories, Inc. - Form 483, 2002-02-26
January, 2002 FDA 483 Response Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483R, 2002-02-25
March, 2004 FDA 483 ENDO USA, Inc. - Form 483, 2004-03-08
February, 2003 EIR Novartis Pharmaceuticals Corp. - EIR, 2003-02-21
January, 2002 EIR Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2002-01-24
April, 2000 FDA 483 Response Barr Laboratories, Inc. - Form 483R, 2000-06-28
December, 2013 EIR Epic Pharma, LLC - EIR, 2013-12-23
November, 2007 EIR Patheon UK Limited - EIR, 2007-11-09
November, 2007 FDA 483 Response Patheon UK Limited - Form 483R, 2007-12-07
October, 2000 FDA 483 Ingenus Pharmaceuticals NJ LLC - Form 483, 2000-10-17
April, 2001 FDA 483 Response Strides Pharma, Inc - Form 483R, 2001-04-30
February, 2000 FDA 483 Merck, Inc. - Form 483, 2000-02-25
November, 2002 EIR Barr Laboratories Inc. - EIR, 2002-11-12
August, 2000 EIR Barr Laboratories, Inc. - EIR, 2000-08-28
August, 2001 FDA 483 Pfizer Inc. - Form 483, 2001-08-07
April, 2000 EIR Barr Laboratories, Inc. - EIR, 2000-04-17
January, 2001 FDA 483 Response Merck, Inc. - Form 483R, 2001-02-16
April, 2001 FDA 483 Strides Pharma, Inc - Form 483, 2001-04-10
November, 2002 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2003-02-26
December, 2004 EIR Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2004-12-10
September, 2013 EIR ScieGen Pharmaceuticals INC - EIR, 2013-09-18
August, 2000 FDA 483 Response Halo Pharmaceuticals Inc. - Form 483R, 2000-08-29
February, 2000 EIR Merck, Inc. - EIR, 2000-02-25
April, 2001 EIR Strides Pharma, Inc - EIR, 2001-04-10
July, 2004 EIR Pfizer Inc. - EIR, 2004-07-29
March, 2001 FDA 483 Pfizer, Inc. - Form 483, 2001-03-02
February, 2001 EIR Maypro Industries, Inc. - EIR, 2001-02-13
January, 2002 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2002-01-24
August, 2000 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2000-08-04
March, 2004 EIR ENDO USA, Inc. - EIR, 2004-03-08
April, 2005 EIR Watson Laboratories, Inc. - EIR, 2005-04-28
May, 2004 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2004-05-21
June, 2004 FDA 483 Response Strides Pharma, Inc - Form 483R, 2004-07-16
October, 2001 EIR Perrigo New York, Inc. - EIR, 2001-10-26
June, 2004 EIR Strides Pharma, Inc - EIR, 2004-06-22
October, 2004 EIR Strides Pharma, Inc - EIR, 2004-10-05
July, 2002 EIR SML Acquisition, LLC (aka San-mar Laboratories, Inc) - EIR, 2002-07-11
February, 2003 FDA 483 Response Novartis Pharmaceuticals Corp. - Form 483R, 2003-03-07
August, 2000 FDA 483 Barr Laboratories, Inc. - Form 483, 2000-08-28
May, 2000 FDA 483 Actavis Totowa LLC - Form 483, 2000-05-23
May, 2003 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2003-08-05
April, 2005 FDA 483 Watson Laboratories, Inc. - Form 483, 2005-04-28
February, 2000 FDA 483 Merck, Inc. - Form 483, 2000-02-25
May, 2013 EIR Excella GmbH & Co. KG - EIR, 2013-05-17
April, 2000 FDA 483 Barr Laboratories, Inc. - Form 483, 2000-04-17
September, 2002 FDA 483 Geritrex, LLC - Form 483, 2002-09-18
February, 2000 FDA 483 Response Merck, Inc. - Form 483R, 2000-03-20
January, 2001 FDA 483 Merck, Inc. - Form 483, 2001-01-19
November, 2007 FDA 483 Patheon UK Limited - Form 483, 2007-11-09
May, 2000 EIR Actavis Totowa LLC - EIR, 2000-05-23
December, 2002 FDA 483 Sanofi-Aventis U.S. LLC - Form 483, 2002-12-19
July, 2004 FDA 483 Response Pfizer Inc. - Form 483R, 2004-08-27
June, 2004 FDA 483 Strides Pharma, Inc - Form 483, 2004-06-22
August, 2001 EIR Pfizer Inc. - EIR, 2001-08-07
May, 2000 FDA 483 Response Actavis Totowa LLC - Form 483R, 2000-07-02
January, 2001 EIR Merck, Inc. - EIR, 2001-01-19
July, 2004 FDA 483 Pfizer Inc. - Form 483, 2004-07-29
July, 2003 FDA 483 Perrigo New York, Inc. - Form 483, 2003-07-10
February, 2003 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2003-02-21
September, 2001 EIR Taro Pharmaceuticals U.S.A., Inc. - EIR, 2001-09-17
May, 2003 EIR Barr Laboratories Inc. - EIR, 2003-05-09
August, 2000 EIR Halo Pharmaceuticals Inc. - EIR, 2000-08-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more